|
LoxitaneDrug - Loxitane The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Loxapine Succinate
Strength -
EQ 25MG BASE
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
017525
Product Number -
007
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Loxitane
Loxitane Eq 10mg Base Capsule; Oral
Loxitane Eq 25mg Base Capsule; Oral Loxitane Eq 50mg Base Capsule; Oral Loxitane Eq 5mg Base Capsule; Oral Loxitane Eq 10mg Base Tablet; Oral Loxitane Eq 25mg Base Tablet; Oral Loxapine Succinate Eq 10mg Base Capsule; Oral Loxapine Succinate Eq 25mg Base Capsule; Oral Loxapine Succinate Eq 50mg Base Capsule; Oral Loxapine Succinate Eq 5mg Base Capsule; Oral NewDrugInformation |